Lanean...
Cutaneous leukocytoclastic vasculitis associated with erlotinib treatment: A case report and review of the literature
Erlotinib is a targeted anticancer therapy used for treating epidermal growth factor receptor (EGFR) mutation positive lung cancer in advanced stage as well as for other malignancies. The most common cutaneous side effect of erlotinib, are well documented; however the number of reports regarding cut...
Gorde:
| Argitaratua izan da: | Exp Ther Med |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
D.A. Spandidos
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327513/ https://ncbi.nlm.nih.gov/pubmed/30679984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.6988 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|